Adel Mahmoud - Net Worth and Insider Trading

Adel Mahmoud Net Worth

The estimated net worth of Adel Mahmoud is at least $360 dollars as of 2024-05-05. Adel Mahmoud is the Director of Genvec Inc and owns about 50 shares of Genvec Inc (GNVC) stock worth over $360. Details can be seen in Adel Mahmoud's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adel Mahmoud has not made any transactions after 2011-09-06 and currently still holds the listed stock(s).

Transaction Summary of Adel Mahmoud

To

Adel Mahmoud Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Adel Mahmoud owns 3 companies in total, including Inovio Pharmaceuticals Inc (INO) , Becton Dickinson & Co (BDX) , and Genvec Inc (GNVC) .

Click here to see the complete history of Adel Mahmoud’s form 4 insider trades.

Insider Ownership Summary of Adel Mahmoud

Ticker Comapny Transaction Date Type of Owner
INO Inovio Pharmaceuticals Inc 2016-05-08 director
BDX Becton Dickinson & Co 2006-07-25 director
GNVC Genvec Inc 2012-07-11 director

Adel Mahmoud Latest Holdings Summary

Adel Mahmoud currently owns a total of 1 stock. Adel Mahmoud owns 50 shares of Genvec Inc (GNVC) as of September 6, 2011, with a value of $360.

Latest Holdings of Adel Mahmoud

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GNVC Genvec Inc 2011-09-06 50 7.19 360

Holding Weightings of Adel Mahmoud


Adel Mahmoud Form 4 Trading Tracker

According to the SEC Form 4 filings, Adel Mahmoud has made a total of 0 transactions in Genvec Inc (GNVC) over the past 5 years. The most-recent trade in Genvec Inc is the acquisition of 50 shares on September 6, 2011, which cost Adel Mahmoud around $1,380.

Insider Trading History of Adel Mahmoud

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Adel Mahmoud Trading Performance

GuruFocus tracks the stock performance after each of Adel Mahmoud's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adel Mahmoud is 1.08%. GuruFocus also compares Adel Mahmoud's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adel Mahmoud within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Adel Mahmoud's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Adel Mahmoud

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.5
Relative Return to S&P 500(%) 6.52

Adel Mahmoud Ownership Network

Ownership Network List of Adel Mahmoud

No Data

Ownership Network Relation of Adel Mahmoud


Adel Mahmoud Owned Company Details

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Adel Mahmoud is the director of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and CFO Peter Kies .

Inovio Pharmaceuticals Inc (INO) Insider Trades Summary

Over the past 18 months, Adel Mahmoud made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 17,501 shares made by David B. Weiner , and a net sale of 5,700 shares made by Lota S. Zoth .

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,933 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,933 shares.

Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

Adel Mahmoud Mailing Address

Above is the net worth, insider trading, and ownership report for Adel Mahmoud. Currently GuruFocus does not have mailing address information for Adel Mahmoud.

Discussions on Adel Mahmoud

No discussions yet.